Vulnerability Details : CVE-2017-20060
A vulnerability, which was classified as problematic, was found in Elefant CMS 1.3.12-RC. This affects an unknown part of the component Blog Post Handler. The manipulation leads to basic cross site scripting (Persistent). It is possible to initiate the attack remotely. Upgrading to version 1.3.13 is able to address this issue. It is recommended to upgrade the affected component.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2017-20060
- cpe:2.3:a:elefantcms:elefant_cms:1.3.12:rc:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2017-20060
0.05%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 16 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2017-20060
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
3.5
|
LOW | AV:N/AC:M/Au:S/C:N/I:P/A:N |
6.8
|
2.9
|
NIST | |
|
3.5
|
LOW | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N |
2.1
|
1.4
|
VulDB | |
|
5.4
|
MEDIUM | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
2.3
|
2.7
|
NIST |
CWE ids for CVE-2017-20060
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
-
The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages.Assigned by: cna@vuldb.com (Secondary)
References for CVE-2017-20060
-
http://seclists.org/fulldisclosure/2017/Feb/36
Full Disclosure: Elefant CMS 1.3.12-RC: Multiple Persistent and Reflected XSSMailing List;Third Party Advisory
-
https://vuldb.com/?id.97257
CVE-2017-20060 | Elefant CMS Blog Post Persistent cross site scritingThird Party Advisory
Jump to